Sex steroid axes in determining male predominance in hepatocellular carcinoma
Sex steroid axes in determining male predominance in hepatocellular carcinoma
复制标题
性类固醇轴决定肝细胞癌中男性的优势
DOI:
10.1016/j.canlet.2022.216037
复制
发表时间:
2023
期刊:
影响因子:
9.7
通讯作者:
Xing Wang
中科院分区:
文献类型:
--
作者:
Lei Zhang;Jinfeng Wu;Qiumei Wu;Xiangjuan Zhang;Shuaicai Lin;Wanli Ran;Zhu Li;Chengyan Tang;Xing Wang
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. The mechanisms for male .propensity in HCC incidence, prognosis and treatment responses are complicated and remain inconclusive. Sex- .biased molecular signatures in carcinogenesis, viral infections and immune responses have been studied pre-.dominantly within the context of sex hormones effects. This review integrates current knowledge on the .mechanisms through which the hormones regulate HCC development in sexually dimorphic fashion. Firstly, the .androgen/androgen receptor (AR) accelerate cell proliferation and virus infection, especially during the initial .stage of HCC, while estrogen/estrogen receptor (ER) function in an opposite way to induce cell apoptosis and .immune responses. Interestingly, the controversial effects of AR in late stage of HCC metastasis are summarized .and the reasons are attributed to inconsistent cancer grading or experimental models between the studies. In .addition, the new insights into these intricate cellular and molecular mechanisms underlying sexual dimorphism .are fully discussed. A detailed understanding of sex hormones-associated regulation to male predominance in .HCC may help to develop personalized therapeutic strategies in high-risk populations.